Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 7, 2005, Pages 821-824

  Bonfield, Tracey L ^a   John, Nejimol ^a   Barna, Barbara P ^a   Kavuru, Mani S ^a   Thomassen, Mary Jane ^a   Yen Lieberman, Belinda ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HUMAN; IMMUNOASSAY; LUNG ALVEOLUS; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; MULTIPLEXED PARTICLE BASED ANTI GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ASSAY; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSORBENT TECHNIQUES; MICROSPHERES; PREDICTIVE VALUE OF TESTS; PULMONARY ALVEOLAR PROTEINOSIS;

EID: 22244468661     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.7.821-824.2005     Document Type: Article

References (20)

1. Biagini, R. E., D. L. Sammons, J. P. Smith, B. A. Mackenzie, C. A. Striley, V. Semenova, E. Steward-dark, K. Stamey, A. E. Freeman, C. P. Quinn, et al. 2004. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-lined immunosorhent assay for measurement of human immunoglohulin G antibodies to anthrax toxins. Clin. Diagn. Lab Immunol. 11:50-55.
2. Bonfield, T. L., M. S. Kavuru, and M. J. Thomassen. 2002. Anti-GM-CSF liter predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin. Immunol. 105:342-350.
3. Bonfield, T. L., D. Russell, S. Burgess, A. Malur, M. S. Kavuru, and M. J. Thomassen. 2002. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am. J. Respir. Cell Mol. Biol. 27:481-486.
4. Earley, M. C., R. F. Vogt, Jr., H. M. Shapiro, F. F. Mandy, K. L. Kellar, R. Bellisario, K. A. Pass, G. E. Marti, C. C. Stewart, and W. H. Hannon. 2002. Report from a workshop on multianalyte microsphere assays. Cytometry 50:239-242.
5. Gilburd, B., M. Abu-Shakra, Y. Shoenfeld, A. Giordano, E. B. Bocci, M. F. delle, and R. Gerli. 2004. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation-a homogeneous, multiplexed system. Clin. Dev. Immunol. 11:53-56.
6. Kavuru, M. S., and M. Popovich. 2002. Therapeutic whole lung lavage: a stop-gap therapy for alveolar proteinosis. Chest 122:1123-1124.
7. Kavuru, M. S., E. J. Sullivan, R. Piccin, M. J. Thomassen, and J. K. Stoller. 2000. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 161:1143-1148.
8. Khan, S. S., M. S. Smith, D. Reda, A. F. Suffredini, and J. P. McCoy, Jr. 2004. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry 61B:35-39.
9. Kitamura, T., N. Tanaka, J. Watanabe, K. Uchida, S. Kanegasaki, Y. Yamada, and K. Nakata. 1999. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 190:875-880.
10. Kitamura, T., K. Uchida, N. Tanaka, T. Tsuchiya, J. Watanabe, Y. Yamada, K. Hanaoka, J. F. Seymour, O. D. Schoch, I. Doyle, Y. Inoue, M. Sakatani, S. Kudoh, A. Azuma, T. Nukiwa, T. Tomita, M. Katagiri, A. Fujita, A. Kurashima, S. Kanegasaki, and K. Nakata. 2000. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 162:658-662.
11. Komatsu, N., S. Shichijo, M. Nakagawa, and K. Itoh. 2004. New multiplexed flow cytometric assay to measure anti-peptidc antibody: a novel tool for monitoring immune responses to peptides used for immunization. Scand. J. Clin. Lab. Investig. 64:535-545.
12. Masaki, Y., and S. Sugai. 2004. Lymphoproliferative disorders in Sjogren's syndrome. Autoimmun. Rev. 3:175-182.
13. Mazzone, P., M. J. Thomassen, and M. Kavuru. 2001. Our new understanding of pulmonary alveolar proteinosis: what an internist needs to know. Clev. Clin. J. Med. 68:977-992.
14. Mazzone, P. J., M. J. Thomassen, and M. S. Kavuru. 2002. Pulmonary alveolar proteinosis: recent advances. Semin. Respir. Crit. Care Med. 23: 115-126.
15. Nakamura, R. M. 2002. Concepts of autoimmunity and autoimmune disease, p. 13-35. In R. M. Nakamura, D. F. Keren, and D. J. Bylund (ed.), Clinical and laboratory evaluation of human autoimmune diseases. American Society for Clinical Pathology, Chicago, Ill.
16. Seymour, J. F., and J. J. Presneill. 2002. Pulmonary alveolar proteinosis (progress in the first 44 years). Am. J. Respir. Crit. Care Med. 166:215-235.
17. Shah, P. L., D. Hansell, P. R. Lawson, K. B. M. Reid, and C. Morgan. 2000. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 55:67-77.
18. Thomassen, M. J., T. Yi, B. Raychaudhuri, A. Malur, and M. S. Kavuru. 2000. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin. Immunol. 95:85-92.
19. Trapnell, B. C., J. A. Whitsett, and K. Nakata. 2003. Pulmonary alveolar proteinosis. N. Engl. J. Med. 349:2527-2539.
20. Vignali, D. A. 2000. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 243:243-255.